Combination of Cisplatin, Ifosfamide, and Irinotecan with rhG-CSF Support for the Treatment of Refractory or Relapsed Small-Cell Lung Cancer

Publisher： Karger

E-ISSN： 1423-0232|59|2|105-109

ISSN： 0030-2414

Source： Oncology, Vol.59, Iss.2, 2000-08, pp. : 105-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination Chemotherapy of Cisplatin, Ifosfamide, and Irinotecan with rhG-CSF Support in Patients with Brain Metastases from Non-Small Cell Lung Cancer

Oncology, Vol. 59, Iss. 4, 2000-11 ,pp. : 291-295

Karger

Access to resources Recommend Favorite

Phase I Study of Cisplatin, Ifosfamide and Irinotecan with rhG-CSF Support in Advanced Non-Small Cell Lung Cancer

Oncology, Vol. 56, Iss. 4, 1999-05 ,pp. : 301-307

Karger

Access to resources Recommend Favorite

Vinorelbine and Alternating Cisplatin and Ifosfamide in the Treatment of Non-Small Cell Lung Cancer

Oncology, Vol. 58, Iss. 1, 2000-01 ,pp. : 25-30

Karger

Access to resources Recommend Favorite

A Multicenter Phase II Study of the Combination of Irinotecan and Gemcitabine in Previously Treated Patients with Small-Cell Lung Cancer

Oncology, Vol. 66, Iss. 3, 2004-06 ,pp. : 192-196

Karger

Access to resources Recommend Favorite

Dose Escalation Study of Amrubicin in Combination with Fixed-Dose Irinotecan in Patients with Extensive Small-Cell Lung Cancer

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 7-11

Karger

Access to resources Recommend Favorite